Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportGeneral Clinical Specialties

The oxyphilic variants of differentiated thyroid carcinoma: Analysis of 135 patients with follicular Huerthle cell carcinoma and papillary thyroid carcinoma with Huerthle cells

Mona Mustafa, Harun Ilhan, Julia Geisler, Peter Bartenstein and Axel Rominger
Journal of Nuclear Medicine May 2014, 55 (supplement 1) 147;
Mona Mustafa
1Nuclear Medicine, Ludwig-Maximilian University Munich, Munich, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Harun Ilhan
1Nuclear Medicine, Ludwig-Maximilian University Munich, Munich, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Julia Geisler
1Nuclear Medicine, Ludwig-Maximilian University Munich, Munich, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Peter Bartenstein
1Nuclear Medicine, Ludwig-Maximilian University Munich, Munich, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Axel Rominger
1Nuclear Medicine, Ludwig-Maximilian University Munich, Munich, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Abstract

147

Objectives The descriptive term oxyphilic variant of DTC has not conclusively been investigated. Oxyphilic( =oncocytic) follicular carcinoma (syn. Huerthle Cell Carcinoma HCC) is commonly connotated with slightly poorer prognosis and putative lack of radioiodine uptake. This study reviewed 135 patients with oxyphilic follicular or papillary carcinoma that were treated by radioiodine ablation in our department between 1998 and 2011 with regards to initial staging of extent and invasiveness.

Methods Patients with oxyphilic follicular carcinoma (n=90) and oxyphilic papillary carcinoma (n=45) were included. Patients with other variants of DTC (tall cell etc.) and poorly differentiated TC were excluded. All pts had undergone total thyroidectomy, in 96 pts (71%) lymphadenectomy had been performed on. A patient cohort with non-oxyphilic DTC (n= 930: PTC n= 795; FTC n=135) treated in our department was used for comparison. Age at diagnose, gender, tumor size and multifocality, lymph node and distant metastases at initial diagnose were assessed.

Results Patients with oxyphilic variants proved to be significantly older than pts with PTC (58 yr vs. 50 yr; p<0.05), whereas gender distribution was similar. Oxyphilic tumors were more often multifocal and larger than FTC. Rates of lymphatic and distant metastases at diagnose were similar to those of FTC rather than PTC (lymph node metastases oxyphilic group 10% vs. 20% PTC and 8% FTC; distant met oxyphilic group 9% vs. 1% PTC and 18% FTC).

Conclusions This study suggests on one of the largest datasets of patients with oxyphilic tumors that these variants of FTC and PTC do not differ significantly from each other but have initial features that are more similar to non-oxyphilic FTC patients. Ongoing evaluation is indicating less radioiodine uptake in persistant metastases of patients with oxyphilic variants of DTC than in non-oxyphilic DTC.

Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 55, Issue supplement 1
May 2014
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
The oxyphilic variants of differentiated thyroid carcinoma: Analysis of 135 patients with follicular Huerthle cell carcinoma and papillary thyroid carcinoma with Huerthle cells
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
The oxyphilic variants of differentiated thyroid carcinoma: Analysis of 135 patients with follicular Huerthle cell carcinoma and papillary thyroid carcinoma with Huerthle cells
Mona Mustafa, Harun Ilhan, Julia Geisler, Peter Bartenstein, Axel Rominger
Journal of Nuclear Medicine May 2014, 55 (supplement 1) 147;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
The oxyphilic variants of differentiated thyroid carcinoma: Analysis of 135 patients with follicular Huerthle cell carcinoma and papillary thyroid carcinoma with Huerthle cells
Mona Mustafa, Harun Ilhan, Julia Geisler, Peter Bartenstein, Axel Rominger
Journal of Nuclear Medicine May 2014, 55 (supplement 1) 147;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

General Clinical Specialties

  • Assessing the role of FDG- and NaF-PET/CT in evaluating inflammatory spine disorders
  • Quantitative analysis of COVID-19 associated inflammation using FDG-PET/CT
  • ARRAY OF PET/CT FINDINGS RELATED TO COVID-19 VACCINATION OR INFECTION
Show more General Clinical Specialties

INTEGRATED Session: Advance Management of Thyroid Cancer

  • Clinical value of whole body [18F]FDG-PET/CT in the detection of metastatic medullary thyroid cancer
  • Predictive value of FDG PET at initial radioiodine therapy for survival of high-risk patients with differentiated thyroid cancer
  • What is the impact of pre-ablation 131-I scintigraphy with SPECT-CT on thyroid cancer management?
Show more INTEGRATED Session: Advance Management of Thyroid Cancer

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire